Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. H. Muskiet · SciRah

Researcher profile · Semantic Scholar

M. H. Muskiet

Share profile

M. H. Muskiet — researcher profile on SciRah

h-index: 19
Works: 49
Citations: 2,391

Most-cited papers

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.
L. Tonneijck, M. H. Muskiet, M. Smits, Erik J. M. van Bommel +3 more
2017Journal of the American Society of Nephrology739 citations Open access
Semantic Scholar
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
Erik J. M. van Bommel, M. H. Muskiet, L. Tonneijck, M. Kramer +2 more
2017American Society of Nephrology. Clinical Journal209 citations Open access
Semantic Scholar
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
N. J. van der Zijl, G. Goossens, C. Moors, D. V. van Raalte +4 more
2011Journal of Clinical Endocrinology and Metabolism202 citations Open access
Semantic Scholar
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
M. H. Muskiet, M. Smits, L. Morsink, M. Diamant
2014Nature Reviews Nephrology200 citations
Semantic Scholar
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
M. Smits, L. Tonneijck, M. H. Muskiet, M. Kramer +6 more
2016Diabetologia136 citations Open access
Semantic Scholar
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial
D. V. van Raalte, M. Brands, N. J. van der Zijl, M. H. Muskiet +5 more
2011Diabetologia117 citations Open access
Semantic Scholar
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
L. Tonneijck, M. Smits, M. H. Muskiet, T. Hoekstra +6 more
2016Diabetes Care106 citations Open access
Semantic Scholar
Saturated fat, carbohydrates and cardiovascular disease.
R. Kuipers, D. D. de Graaf, M. F. Luxwolda, M. H. Muskiet +2 more
2011Netherlands Journal of Medicine78 citations
Semantic Scholar
Gastrointestinal actions of glucagon‐like peptide‐1‐based therapies: glycaemic control beyond the pancreas
M. Smits, L. Tonneijck, M. H. Muskiet, M. Kramer +2 more
2016Diabetes, obesity and metabolism72 citations Open access
Semantic Scholar
Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males.
M. Smits, M. H. Muskiet, L. Tonneijck, T. Hoekstra +3 more
2016British Journal of Clinical Pharmacology62 citations Open access
Semantic Scholar
Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
M. Smits, L. Tonneijck, M. H. Muskiet, T. Hoekstra +6 more
2016Diabetes, obesity and metabolism55 citations Open access
Semantic Scholar
GLP-1 based therapies: clinical implications for gastroenterologists
M. Smits, D. V. van Raalte, L. Tonneijck, M. H. Muskiet +2 more
2016Gut55 citations Open access
Semantic Scholar
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
M. Smits, L. Tonneijck, M. H. Muskiet, T. Hoekstra +3 more
2017European Journal of Endocrinology50 citations Open access
Semantic Scholar
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.
Renate E. van Genugten, D. V. van Raalte, M. H. Muskiet, M. Heymans +4 more
2014European Journal of Endocrinology43 citations
Semantic Scholar
GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men
M. Smits, M. H. Muskiet, L. Tonneijck, M. Kramer +3 more
2015Arteriosclerosis, Thrombosis and Vascular Biology37 citations Open access
Semantic Scholar
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
M. Smits, L. Tonneijck, M. H. Muskiet, T. Hoekstra +5 more
2015BMJ Open32 citations Open access
Semantic Scholar
GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
M. Smits, L. Tonneijck, M. H. Muskiet, T. Hoekstra +4 more
2016Arteriosclerosis, Thrombosis and Vascular Biology27 citations Open access
Semantic Scholar
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial
M. Smits, L. Tonneijck, M. H. Muskiet, M. Kramer +7 more
2016Diabetes Care24 citations Open access
Semantic Scholar
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes.
Erik J. M. van Bommel, M. Smits, Danique Ruiter, M. H. Muskiet +6 more
2020Journal of Hypertension20 citations Open access
Semantic Scholar
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial.
M. H. Muskiet, M. Bunck, R. J. Heine, A. Cornér +6 more
2019Diabetes Research and Clinical Practice19 citations
Semantic Scholar
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients.
M. Smits, L. Tonneijck, M. H. Muskiet, T. Hoekstra +3 more
2017Diabetes Research and Clinical Practice17 citations Open access
Semantic Scholar
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?
L. Tonneijck, M. H. Muskiet, M. Smits, D. V. van Raalte +1 more
2014The Lancet Diabetes and Endocrinology15 citations
Semantic Scholar
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
Suvanjaa Sivalingam, E. L. Larsen, D. V. van Raalte, M. H. Muskiet +11 more
2021Scientific Reports14 citations Open access
Semantic Scholar
Incretin-based drugs and renoprotection-is hyperfiltration key?
L. Tonneijck, M. Smits, D. V. van Raalte, M. H. Muskiet
2015Kidney International13 citations Open access
Semantic Scholar
Uncomplicated human type 2 diabetes is associated with meal-induced blood pressure lowering and cardiac output increase.
M. Smits, M. H. Muskiet, M. Tushuizen, K. A. Kwa +3 more
2014Diabetes Research and Clinical Practice9 citations
Semantic Scholar
Pancreatic Steatosis Is Not Associated With Exocrine Pancreatic Function in Overweight Type 2 Diabetes Patients.
K. Vendrik, L. Tonneijck, M. H. Muskiet, M. Kramer +6 more
2017Pancreas7 citations Open access
Semantic Scholar
Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
M. Smits, L. Tonneijck, M. H. Muskiet, M. Diamant +3 more
2017Diabetic Medicine7 citations Open access
Semantic Scholar
Glucagon‐like peptide‐1 receptor agonist exenatide has no acute effect on MRI‐measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial
M. Smits, L. Tonneijck, M. H. Muskiet, M. Kramer +4 more
2016Diabetes, obesity and metabolism7 citations Open access
Semantic Scholar
Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function.
D. V. van Velzen, M. Smits, Erik J. M. van Bommel, M. H. Muskiet +7 more
2021AJP - Renal Physiology5 citations
Semantic Scholar
Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study
E. J. Bouman, M. Smits, Erik J. M. van Bommel, M. H. Muskiet +4 more
2021Microcirculation4 citations Open access
Semantic Scholar
GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials.
M. Smits, J. T. ten Kulve, L. van Bloemendaal, L. Tonneijck +4 more
2019Nutrition (Burbank, Los Angeles County, Calif.)4 citations Open access
Semantic Scholar
250-OR: Beta-Cell Rest Induced by Dapagliflozin Improves ß-Cell Secretory Capacity in Type 2 Diabetes Patients: A Randomized Controlled Trial vs. Gliclazide
Erik J. M. van Bommel, M. H. Muskiet, M. V. van Baar, M. Kramer +3 more
2019Diabetes3 citations
Semantic Scholar
Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial.
Ilse G. Pranger, D. V. van Raalte, M. Brands, M. H. Muskiet +5 more
2018Prostaglandins, Leukotrienes and Essential Fatty Acids3 citations
Semantic Scholar
High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients.
K. Overbeek, N. Krak, I. Pieters, M. Smits +7 more
2020Pancreas2 citations Open access
Semantic Scholar
C-reactive protein mediates the association of liver fat and carotid intima–media thickness in healthy men and men with the metabolic syndrome and/or uncomplicated type 2 diabetes
N. J. van der Zijl, M. H. Muskiet, M. Tushuizen, L. Rijzewijk +6 more
20102 citations Open access
Semantic Scholar
Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
L. Tonneijck, M. Smits, M. H. Muskiet, T. Hoekstra +6 more
2019Diabetes Care1 citations Open access
Semantic Scholar
Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089–1098
M. Smits, M. H. Muskiet, L. Tonneijck, D. V. van Raalte
2015Diabetes Care1 citations Open access
Semantic Scholar
Should dietary SFA be exchanged for linoleic acid?
F. Muskiet, M. H. Muskiet
2012American Journal of Clinical Nutrition1 citations Open access
Semantic Scholar
Association of Liver Fat and Carotid Intima Media Thickness Is Mediated by C-Reactive Protein in Men with the Metabolic Syndrome and/or Uncomplicated Type 2 Diabetes
M. H. Muskiet, N. J. van der Zijl, M. Tushuizen, L. Rijzewijk +2 more
20091 citations
Semantic Scholar
PS13 - 6. DPP-4 inhibition as preventive strategy for the diabetogenic effects of glucocorticoids in men with the metabolic syndrome – a randomised controlled trial
R. E. van Genugten, D. V. van Raalte, M. H. Muskiet, M. Heymans +4 more
2013Nederlands Tijdschrift voor Diabetologie0 citations
Semantic Scholar
PS9 - 4. Changes in Circadian Haemodynamics and Autonomic Nervous System Balance in Non- Hypertensive Uncomplicated Type 2 Diabetes
M. H. Muskiet, M. Smits, M. Tushuizen, K. A. Kwa +2 more
2013Nederlands Tijdschrift voor Diabetologie0 citations
Semantic Scholar
4 Liver fat content is related to postprandial triglyceride-enrichment of HDL particles in association with endothelial and HDL dysfunction
M. Tushuizen, P. Scheffer, M. H. Muskiet, R. Vermue +2 more
20120 citations
Semantic Scholar
Arterial stiffness associates with changes in subpopulations of microparticles during postprandial conditions in males with and without the metabolic syndrome
M. Tushuizen, R. Nieuwland, M. H. Muskiet, C. Rustemeijer +2 more
20120 citations
Semantic Scholar
renal manifestations in autosomal dominant polycystic kidney disease : a dichotomy of two ends of a spectrum 367
W. E. Schouten, J. J. M. van Gulick, T. Gevers, L. van Keimpema +8 more
20110 citations
Semantic Scholar
73 Hepatic Fat Accumulation Promotes Postprandial Triglyceride-Enrichment of HDL Particles in Association With Endothelial Dysfunction in Men With the Metabolic Syndrome and Men With Type 2 Diabetes
M. Tushuizen, P. Scheffer, M. H. Muskiet, R. Vermue +3 more
20100 citations Open access
Semantic Scholar
Pancreatic fat content and abdominal fat compartments in relation to beta-cell function in subjects with impaired glucose metabolism
N. J. van der Zijl, G. Goossens, C. Moors, D. V. van Raalte +4 more
20100 citations
Semantic Scholar
C-reactive protein mediates the association of liver fat and carotid intima media thickness in men with the metabolic syndrome and/or type 2 diabetes
N. J. van der Zijl, M. H. Muskiet, M. Tushuizen, L. Rijzewijk +2 more
20090 citations
Semantic Scholar
Liver fat associates with postprandial triglyceride-enrichment of HDL particles and endothelial dysfunction in men with type 2 diabetes and men with the metabolic syndrome
M. Tushuizen, P. Scheffer, M. H. Muskiet, R. Vermue +3 more
20090 citations
Semantic Scholar
Incretin-based drugs 4 Combining incret in-based drugs and RAAS inhib i tors : more cons than pros ?
L. Tonneijck, M. H. Muskiet, D. V. van Raalte, M. Diamant
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. V. van Raalte×38
Invite
D. V. van Raalte — researcher profile on SciRah
M. Diamant×30
Invite
M. Diamant — researcher profile on SciRah
M. Smits×29
Invite
M. Smits — researcher profile on SciRah
L. Tonneijck×25
Invite
L. Tonneijck — researcher profile on SciRah

×21

Invite

M. Kramer — researcher profile on SciRah

Invite

P. Pouwels — researcher profile on SciRah

T. Hoekstra×10

Invite

T. Hoekstra — researcher profile on SciRah

Invite

D. Cahen — researcher profile on SciRah

M. Tushuizen×9

Invite

M. Tushuizen — researcher profile on SciRah

Invite

J. Joles — researcher profile on SciRah

Erik J. M. van Bommel×6

Invite

Erik J. M. van Bommel — researcher profile on SciRah

N. J. van der Zijl×6

Invite

N. J. van der Zijl — researcher profile on SciRah